Rituximab for Autoimmune Retinopathy
|ClinicalTrials.gov Identifier: NCT01086631|
Recruitment Status : Completed
First Posted : March 15, 2010
Last Update Posted : October 6, 2017
National Eye Institute (NEI)
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Eye Institute (NEI) )
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Primary Completion Date :||No date given|
|Actual Study Completion Date :||July 8, 2014|
Weinstein JM, Kelman SE, Bresnick GH, Kornguth SE. Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma. Ophthalmology. 1994 Jul;101(7):1236-43.
Jacobson DM, Thirkill CE, Tipping SJ. A clinical triad to diagnose paraneoplastic retinopathy. Ann Neurol. 1990 Aug;28(2):162-7.